leadf
logo-loader
viewDeltex Medical Group plc

Deltex Medical Group PLC poised for rapid US growth

Deltex Medical Group plc (LON:DEMG) would not be the first British company to find a more welcome reception in the USA than in its home, and it has just announced that its US sales have overtaken those from the UK for the first time.
Chief executive officer Ewan Philips tells Proactive Investors that the company now has 27 “platform accounts” in the USA, which will form a bridgehead for its US sales initiatives. Sadly, back in Blighty, despite masses of evidence pointing to the superiority of its oesophageal Doppler monitoring technology (ODM) and a recommendation that it should be taken up by UK hospitals, inertia rules the day. Philips says the company has reverted to its old sales policy of “knocking on surgery doors” to persuade surgeons of the benefits of ODM.

Quick facts: Deltex Medical Group plc

Price: 1.27 GBX

AIM:DEMG
Market: AIM
Market Cap: £6.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Tetra Bio-Pharma completes toxicology studies on coronavirus candidate,...

Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) CEO Guy Chamberland tells Proactive it has completed toxicology studies on its coronavirus drug candidate ARDS-003, clearing the path for human clinical trials. Chamberland says next steps include structuring the applications to begin in-human...

45 minutes ago

2 min read